Literature DB >> 7847848

Effect of doxorubicin on glutathione and glutathione-dependent enzymes in cultured rat heart cells.

N S Paranka1, R T Dorr.   

Abstract

The effect of doxorubicin (DOX) on heart cell glutathione (GSH)-based enzyme systems was investigated in a rat heart myocyte model. Cellular levels of GSH decreased commensurate with viability following exposure to DOX or to the unrelated alkaloidal cardiotoxin emetine. GSH depletion by L-buthionine sulfoximine (L-BSO) did not alter myocyte viability nor doxorubicin (DOX) dose-response. The nitrosourea carmustine (BCNU), which impairs GSH reductase activity, also did not alter DOX cardiotoxicity. Doxorubicin significantly increased glutathione-S-transferase (GST) activity in a time-dependent fashion. In contrast, selenium-dependent glutathione peroxidase activity was reduced by 50%. These findings demonstrate that lowered GSH or GSH reductase levels do not enhance DOX cardiotoxicity in vitro and suggest that DOX may be a substrate for GST.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7847848

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Molecular biology of doxorubicin-induced cardiomyopathy.

Authors:  J Umlauf; M Horký
Journal:  Exp Clin Cardiol       Date:  2002

2.  Activation of the aryl hydrocarbon receptor by doxorubicin mediates cytoprotective effects in the heart.

Authors:  Maria Volkova; Monica Palmeri; Kerry S Russell; Raymond R Russell
Journal:  Cardiovasc Res       Date:  2011-01-13       Impact factor: 10.787

3.  Mrp1 localization and function in cardiac mitochondria after doxorubicin.

Authors:  Paiboon Jungsuwadee; Ramaneeya Nithipongvanitch; Yumin Chen; Terry D Oberley; D Allan Butterfield; Daret K St Clair; Mary Vore
Journal:  Mol Pharmacol       Date:  2009-02-20       Impact factor: 4.436

4.  Troglitazone reduces glyoxalase I protein expression in glioma and potentiates the effects of chemotherapeutic agents.

Authors:  Jeffrey Helgager; Jie Li; Irina A Lubensky; Russell Lonser; Zhengping Zhuang
Journal:  J Oncol       Date:  2010-05-04       Impact factor: 4.375

5.  Increased myocardial 18F-FDG uptake as a marker of Doxorubicin-induced oxidative stress.

Authors:  Matteo Bauckneht; Fabio Pastorino; Patrizia Castellani; Vanessa Cossu; Anna Maria Orengo; Patrizia Piccioli; Laura Emionite; Selene Capitanio; Nikola Yosifov; Silvia Bruno; Edoardo Lazzarini; Mirco Ponzoni; Pietro Ameri; Anna Rubartelli; Silvia Ravera; Silvia Morbelli; Gianmario Sambuceti; Cecilia Marini
Journal:  J Nucl Cardiol       Date:  2019-02-08       Impact factor: 5.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.